SCHEMBL6566826

SCHEMBL6566826

COC(=O)c1cc(NC(=O)NCc2ccccc2)ccc1OC(c1ccccc1)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.54
ALDH1A1 P00352 2/20 0.54
KDM4E B2RXH2 1/20 0.54
CASR P41180 2/20 0.53
ESRRA P11474 2/20 0.49
MAPT P10636 2/20 0.48
NAMPT P43490 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.47
RAB9A P51151 3/20 0.46
NPC1 O15118 2/20 0.46
ITGB3 P05106 1/20 0.46
ITGAV P06756 1/20 0.46
ROCK2 O75116 1/20 0.46
ROCK1 Q13464 1/20 0.46
GSK3B P49841 1/20 0.46
MEN1 O00255 1/20 0.46
LMNA P02545 1/20 0.46
KMT2A Q03164 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
PTPRF P10586 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6566529 0.93 ALDH1A1 (0.56) ALDH1A1CASRNAMPTL3MBTL1ITGB3
SCHEMBL6566505 0.90 LMNA (0.51) GAAALDH1A1KDM4ECASRNAMPT
SCHEMBL6565755 0.90 L3MBTL1 (0.63) ALDH1A1KDM4ENAMPTL3MBTL1RAB9A
SCHEMBL6566680 0.89 CASR (0.56) CASRESRRAMAPTRAB9ANPC1
SCHEMBL6567996 0.88 GAA (0.53) GAAALDH1A1CASRL3MBTL1RAB9A
SCHEMBL6566741 0.88 MEN1 (0.52) GAAALDH1A1CASRMAPTRAB9A
SCHEMBL6566611 0.88 CASR (0.54) ALDH1A1KDM4ECASRESRRAROCK2
SCHEMBL6564786 0.86 KMT2A (0.61) GAAALDH1A1KDM4ECASRMAPT
SCHEMBL6566675 0.86 CASR (0.57) ALDH1A1KDM4ECASRESRRAMAPT
SCHEMBL6566654 0.86 CASR (0.52) CASRESRRAMAPTMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-12-23 US disclosed
EP-1437344-A1 BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2004-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof HRH4, HRH2, HRH1 GAA 3305/4885ALDH1A1 907/4885KDM4E 2962/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.